Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

ProstamaxvsTestagen

Prostate-specific tetrapeptide bioregulator (Lys-Glu-Asp-Pro) that normalizes prostatic epithelial differentiation through chromatin remodeling at prostate gene promoters, restores the proliferation-apoptosis balance disrupted in benign prostatic hyperplasia, and reduces inflammatory cytokine signaling in aging prostate tissue

Testicular tetrapeptide bioregulator (Lys-Glu-Asp-Gly) that normalizes HPG axis signaling through DNA minor groove binding at testicular gene promoters, increases testosterone synthesis by restoring Leydig cell function, and modulates neuroendocrine feedback loops controlling gonadotropin secretion in aging males

Hormone SupportHormone Support

At a Glance

Quick
comparison

Dose Range

Prostamax

5–10 mg

Testagen

5–10 mg

Frequency

Prostamax

Once daily

Testagen

Once daily

Administration

Prostamax

Sublingual (enteric-coated capsules)

Testagen

Sublingual (enteric-coated capsules)

Cycle Length

Prostamax

12+ weeks

Testagen

12+ weeks

Onset Speed

Prostamax

Gradual (3-4 weeks)

Testagen

Gradual (3-4 weeks)

Evidence Level

Prostamax

Limited human trials

Testagen

Limited human trials

Efficacy

Benefit
ratings

Prostamax
Testagen

Growth

Prostamax87%
Testagen0%

Inflammation

Prostamax91%
Testagen0%

Hormone Support

Prostamax85%
Testagen85%

Technical Data

Compound
specifications

Prostamax

Molecular Formula

C20H33N5O9

Molecular Weight

487.5 g/mol

Half-Life

Short plasma half-life typical of tetrapeptides (minutes to hours); biological effects persist for weeks to months through chromatin remodeling at prostate gene promoters; metabolized to constituent amino acids

Bioavailability

Absorbed via intestinal peptide transporters (PepT1) in oral formulation; rapid absorption from subcutaneous injection sites; efficient cellular uptake due to short tetrapeptide structure with proline conferring conformational stability

CAS Number

Not publicly registered

Testagen

Molecular Formula

C17H29N5O9

Molecular Weight

447.4 g/mol

Half-Life

Short plasma half-life typical of tetrapeptides (minutes to hours); biological effects persist for weeks to months through epigenetic modifications to testicular gene expression; metabolized to constituent amino acids

Bioavailability

Absorbed via intestinal peptide transporters (PepT1) in oral formulation; rapid absorption from subcutaneous injection sites; efficient cellular uptake and nuclear penetration due to short tetrapeptide structure

CAS Number

Not publicly registered

Protocols

Dosing
tiers

Prostamax

starting

1-2 capsules (5 mg each) orally once daily

Once daily

10 days initial assessment

Begin with oral capsule administration on an empty stomach. The KEDP tetrapeptide is absorbed through intestinal peptide transporters. Effects on prostate function are gradual — tissue-level changes take weeks to manifest as symptom improvement. Document baseline urinary function (IPSS score if available). Monitor for any changes in urinary patterns.

standard

5-10 mg subcutaneously or 2 capsules orally once daily

Once daily

10-20 days per treatment course

Standard clinical protocol for prostate bioregulation. Administer once daily for 10-20 consecutive days. Repeat courses every 3-6 months for sustained prostate health benefits. Can be combined with Testagen for comprehensive male reproductive support or Epithalon for systemic geroprotection. Urinary symptom improvements typically become noticeable 2-4 weeks after starting treatment.

advanced

10 mg subcutaneously once daily

Once daily

20 days per course

Extended protocol for significant prostatic dysfunction. Used in comprehensive multi-peptide programs combining Prostamax with Testagen (testicular), Epithalon (pineal), Vilon (immune), and Ventfort (vascular) for whole-body male geroprotection. Regular PSA monitoring required. Medical supervision strongly recommended. Repeat courses every 3-6 months.

Testagen

starting

1-2 capsules (5 mg each) orally once daily

Once daily

10 days initial assessment

Begin with oral capsule administration. Take on an empty stomach 15-30 minutes before meals. The KEDG tetrapeptide is designed for oral bioavailability. Effects on testosterone are gradual — HPG axis normalization takes weeks. Baseline testosterone levels should be documented before starting. Monitor for any changes in energy, libido, or mood.

standard

5-10 mg subcutaneously or 2 capsules orally once daily

Once daily

10-20 days per treatment course

Standard protocol as used in the 36-patient clinical trial. Administer once daily for 10-20 consecutive days. Repeat courses every 3-6 months for sustained hormonal support. Can be combined with Prostamax for comprehensive male reproductive health or Epithalon for systemic geroprotection. Testosterone improvements typically become measurable 2-4 weeks after initiating treatment.

advanced

10 mg subcutaneously once daily

Once daily

20 days per course

Extended protocol for significant testicular function decline. Used in comprehensive multi-peptide bioregulator programs combining Testagen with Prostamax (prostate), Epithalon (pineal), Vilon (immune), and Ventfort (vascular) for whole-body male geroprotection. Repeat every 3-6 months. Regular testosterone monitoring recommended. Medical supervision strongly advised.

Applications

Best
suited for

Prostamax

Age-related benign prostatic hyperplasia (BPH) requiring tissue-level normalization

Prostamax is particularly well-suited for individuals focused on age-related benign prostatic hyperplasia (bph) requiring tissue-level normalization. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Prostate geroprotection — preserving prostatic epithelial function during aging

Prostamax is particularly well-suited for individuals focused on prostate geroprotection — preserving prostatic epithelial function during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Chronic prostatitis support through anti-inflammatory tissue-level mechanisms

Prostamax is particularly well-suited for individuals focused on chronic prostatitis support through anti-inflammatory tissue-level mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Comprehensive Khavinson bioregulator protocols targeting male genitourinary health

Prostamax is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting male genitourinary health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Testagen

Age-related testosterone decline (andropause) requiring physiological restoration rather than replacement

Testagen is particularly well-suited for individuals focused on age-related testosterone decline (andropause) requiring physiological restoration rather than replacement. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

HPG axis normalization in aging males with suboptimal hormonal signaling

Testagen is particularly well-suited for individuals focused on hpg axis normalization in aging males with suboptimal hormonal signaling. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Comprehensive Khavinson bioregulator protocols targeting male reproductive health

Testagen is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting male reproductive health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Testicular geroprotection — preserving Leydig and Sertoli cell function during aging

Testagen is particularly well-suited for individuals focused on testicular geroprotection — preserving leydig and sertoli cell function during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety Profile

Side
effects

Prostamax

Common

  • Injection site reaction
  • Mild fatigue
  • Urinary frequency changes
  • Mild headache

Uncommon

  • Mild pelvic discomfort

Serious

  • No documented serious adverse effects

Testagen

Common

  • Injection site reaction
  • Mild fatigue
  • Mild headache
  • Libido fluctuation

Uncommon

  • Mild acne or skin oiliness

Serious

  • No documented serious adverse effects

Research Status

Safety
& evidence

Prostamax

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

Prostamax (proprietary peptide blend) demonstrates limited published safety data; primarily used in clinical practice based on observational evidence. No serious adverse events reported in clinical use; mild gastrointestinal tolerance issues occasionally reported. Derived from bovine prostatic tissue; potential allergenicity in beef-sensitive individuals requires screening. Quality control and standardization vary across manufacturers.

Contraindications

  • xKnown or suspected prostate cancer — potential modulation of prostatic gene expression requires oncological clearance
  • xKnown hypersensitivity to peptide bioregulators or constituent amino acids (lysine, glutamic acid, aspartic acid, proline)
  • xSevere urinary retention requiring surgical intervention — epigenetic therapy cannot address acute obstruction
  • xConcurrent anti-androgen therapy without medical supervision — potential interaction with hormonal mechanisms

Testagen

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

Testagen (lyophilized peptide complex) lacks published human safety data—all information derives from unpublished manufacturer data and theoretical extrapolation from rat studies. As an androgen secretagogue, it carries class risks including erythrocytosis (elevated red blood cell count), liver enzyme elevation, lipid profile unfavorable changes (reduced HDL, increased LDL), and prostate-related effects including urinary obstruction and potential malignancy acceleration. Cardiovascular risk including hypertension and increased thrombotic events are theoretical concerns based on androgen class pharmacology.

Contraindications

  • xKnown hypersensitivity to peptide bioregulators or constituent amino acids (lysine, glutamic acid, aspartic acid, glycine)
  • xHormone-sensitive cancers (prostate, testicular) — potential stimulation of androgen-dependent pathways
  • xPregnancy and breastfeeding (female partners) — not applicable for direct use but consider reproductive implications
  • xSevere hepatic or renal impairment — peptide metabolism may be altered

Decision Guide

Which is
right for you?

Choose Prostamax if...

  • Age-related benign prostatic hyperplasia (BPH) requiring tissue-level normalization
  • Prostate geroprotection — preserving prostatic epithelial function during aging
  • Chronic prostatitis support through anti-inflammatory tissue-level mechanisms
  • Comprehensive Khavinson bioregulator protocols targeting male genitourinary health

Choose Testagen if...

  • Age-related testosterone decline (andropause) requiring physiological restoration rather than replacement
  • HPG axis normalization in aging males with suboptimal hormonal signaling
  • Comprehensive Khavinson bioregulator protocols targeting male reproductive health
  • Testicular geroprotection — preserving Leydig and Sertoli cell function during aging